{
    "Trade/Device Name(s)": [
        "SeptiCyte\u2122 LAB"
    ],
    "Submitter Information": "Immunexpress, Inc.",
    "510(k) Number": "K163260",
    "Predicate Device Reference 510(k) Number(s)": [
        "DEN150009"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PRE"
    ],
    "Summary Letter Date": "November 17, 2016",
    "Summary Letter Received Date": "November 21, 2016",
    "Submission Date": "February 16, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3215"
    ],
    "Regulation Name(s)": [
        "Device to detect and measure non-microbial analyte(s) in human clinical specimens to aid in assessment of patients with suspected sepsis"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "immunology"
    ],
    "Analyte(s)": [
        "CEACAM4",
        "LAMP1",
        "PLA2G7",
        "PLAC8"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "PAXgene\u2122 Blood RNA Tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Applied Biosystems\u00ae 7500 Fast Dx Real-Time PCR System"
    ],
    "Method(s)/Technology(ies)": [
        "Reverse transcription quantitative polymerase chain reaction (RT-qPCR)",
        "Gene expression analysis"
    ],
    "Methodologies": [
        "Gene expression profiling",
        "RT-PCR",
        "Molecular expression testing"
    ],
    "Submission Type(s)": [
        "Kit",
        "Assay",
        "Software",
        "Reagent",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for SeptiCyte\u2122 LAB RT-qPCR gene expression assay measuring host response genes in whole blood to aid sepsis assessment.",
    "Indications for Use Summary": "Aids in differentiating infection-positive (sepsis) from infection-negative systemic inflammation in patients suspected of sepsis on their first day of ICU admission, using whole blood gene expression analysis in conjunction with clinical assessments.",
    "fda_folder": "Microbiology"
}